Development > Corporate partners

Corporate partners

The Academy’s corporate partners allow the organization to pursue its mission by helping to ensure it has the resources it needs. Corporate partner support enhances the offerings available at the Academy’s educational meetings, resident programs, public education, humanitarian, and service programs. It helps provide practice management support and other member resources and underwrites publications such as Dialogues in Dermatology and a variety of other member publications.

The Academy recognizes its corporate partners at five giving levels, and the most committed of our partners, those who have given at the Ruby level and above ($100,000 and up) for three consecutive years, become members of our Corporate Partner Circle.

The Academy extends its thanks to the companies listed below for their generous support in 2011.



2011 Corporate Partner Circle
Abbott Laboratories
Amgen Pfizer
Astellas Pharma US, Inc.
Bayer HealthCare (formerly Intendis, Inc.)
Galderma Laboratories, L.P.
Johnson & Johnson Consumer Products Company
Merz Pharmaceuticals, LLC
Neutrogena Corporation
Ortho Dermatologics
PharmaDerm, a division of Fougera Pharmaceuticals Inc.
Stiefel a GSK company

Diamond Level Contributors ($500,000)
Amgen Pfizer
Neutrogena Corporation

Sapphire Level Contributors ($250,000-$499,999)
Abbott Laboratories
Bayer HealthCare (formerly Intendis, Inc.)
Ortho Dermatologics

Ruby Level Contributors ($100,000-$249,999)
Astellas Pharma US, Inc.
Galderma Laboratories, L.P.
Johnson & Johnson Consumer Products Company
LEO Pharma Inc.
Merz Pharmaceuticals, LLC
NexTech
PharmaDerm, a division of Fougera Pharmaceuticals Inc.
Stiefel a GSK company

Emerald Level Contributors ($50,000 - $99,999)
Allergan, Inc.
Beiersdorf, Inc.
Dermik Laboratories, a business of sanofi-aventis U.S. LLC
Graceway Pharmaceuticals, LLC
Medicis Pharmaceutical Corporation
Proctor & Gamble Company
Upsher-Smith Laboratories, Inc.

 
 

Copyright © 2012 American Academy of Dermatology. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
Contact us | Legal notice